In order to determine changes in glycosylation associated with AR inhibition but not yet in the state of hormonal resistance, we compared the tumor regions derived from patients with hormone sensitive PCa (n = 80 patients) and patients with hormonally-treated PCa (n = 37 patients) (Fig. 3a). Here, AR is linked to neoplasm.